No Data
No Data
Earnings Preview: EBS to Report Financial Results Post-market on May 07
Emergent BioSolutions Gets $65M Deal for Ontario Naloxone Program
Emergent BioSolutions Secures $65 Million Agreement to Supply NARCAN Nasal Spray to Ontario Ministry of Health
Emergent Biosolutions: Announced 3-Yr Agreement With a Value of Approximately $65M to Supply the Ontario Ministry of Health With NARCAN Nasal Spray for the Ontario Naloxone Program >EBS
Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract With Ontario Ministry of Health
Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025